Nu Eyne

We research and develop customized electrical stimulation protocols to control abnormal cellular activity in response to chronic diseases. By mimicking the bodys electrical signals and facilitating communication between different parts of the nervous system, damaged tissues can heal faster, and cancer cell growth can be suppressed. With this technology, the company seeks to overcome the limitations of current treatment options, which often have multiple side effects and low efficacy. Nu Eyne is actively researching the potential applications of its technology in corneal and retinal diseases, as well as tinnitus, facial paralysis, autism, and cancer

Biomedical engineering,medtech,biotechnology,healthcare,medical devices,wearable,tissue engineering,neuromodulation,opthalmology,neurology,psychiatry,urology,oncology,and ent

Nu eyne operates in the Medical equipment manufacturing industry.

Nu eyne's revenue is 11m - 100m

Nu eyne has 11 - 50 employees.